2026年2月6日,上海临港康桥园区。落款为物业服务中心的封条,横亘在璎黎药业的大门之上。公司官网显示“停止运行”,创始人被限制高消费,唯一上市产品被医保目录移除。五年前,它是行业“当红炸子鸡”:恒瑞2000万美元入股背书,国产首个PI3Kδ抑制剂上市在即,被寄予厚望成为肿瘤精准治疗的突破者。从资本宠儿到封条加身,璎黎用五年走完一个完整的坠落周期。它踩中的每一个雷区,都是当下Biotech行业最...
Source Link2026年2月6日,上海临港康桥园区。落款为物业服务中心的封条,横亘在璎黎药业的大门之上。公司官网显示“停止运行”,创始人被限制高消费,唯一上市产品被医保目录移除。五年前,它是行业“当红炸子鸡”:恒瑞2000万美元入股背书,国产首个PI3Kδ抑制剂上市在即,被寄予厚望成为肿瘤精准治疗的突破者。从资本宠儿到封条加身,璎黎用五年走完一个完整的坠落周期。它踩中的每一个雷区,都是当下Biotech行业最...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.